|
- 2019
Long‐term cardiovascular effects of vandetanib and pazopanib in normotensive ratsDOI: 10.1002/prp2.477 Keywords: cardiovascular pharmacology, hypertension, pazopanib, radiotelemetry, receptor tyrosine kinase inhibitors, vandetanib Abstract:
|